Pui San Tan

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Julia Hippisley‐Cox, Duncan Young, Carol Coupland et al. · Heart · 2020 · 374 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study

Paul Aveyard, Min Gao, Nicola Lindson et al. · The Lancet Respiratory Medicine · 2021 · 304 citations · Full text

Medicine, Health Sciences, Internal Medicine +15

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort

Ashley Kieran Clift, Adam Von Ende, Pui San Tan et al. · Thorax · 2021 · 196 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +16

Ten-year survival in women with primary stage IV breast cancer

Lee Guek Eng, Shaheenah Dawood, Victoria Sopik et al. · Breast Cancer Research and Treatment · 2016 · 137 citations

Medicine, Oncology, Breast Oncology +7

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With<i>EGFR</i>-Mutated Advanced Non–Small Cell Lung Cancer

Pedro Nazareth Aguiar, Benjamin Haaland, Wungki Park et al. · JAMA Oncology · 2018 · 123 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +15